Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429969
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
Metabolomic Profile of Vitreoretinal Diseases an NMR-Based Approach Using Vitreous
Sponsor:
Renmin Hospital of Wuhan University
Organization:
Renmin Hospital of Wuhan University
Study Overview
Official Title:
Nuclear Magnetic Resonance NMR-Based Metabolomic Characterisation of Vitreoretinal Diseases Using Vitreous Fluid
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NMR
Brief Summary:
The goal of this observational study was to learn about metabolomics profiles in vitreoretinal diseases by nuclear magnetic resonance NMRusing vitreous fluid The main question it aimed to answer was abnormal biomarkers for common retinal diseases such as idiopathic macular holeIMH diabetic retinopathyDR and retinal detachmentRD Participants would not be subjected to any intervention and the investigators would only collect preoperative information and remaining vitreous samples The investigators divided the participants into groups with appropriate disease names based on the disease diagnosis such as IMH group DR group and RD group The MH group was used as a control group investigators compared other groups to see the metabolomic abnormalities
Detailed Description:
This study aimed to analyze vitreous fluid using NMR to discover potential biomarkers for the prevention early diagnosis and treatment of vitreoretinal diseases and to reveal the mechanisms of disease progression Patients suffering from IMH DR RD idiopathic macular epiretinal membrane IMM and retinal vein occlusion RVO quiring for pars plana vitrectomy PPV who visited Renmin Hospital of Wuhan University were chosen to participate in this study Participants were not subjected to any intervention and the investigator only collected preoperative information and remaining vitreous samples Participants provided preoperative examination information and medical history and the investigators divided the participants into five groups with corresponding disease names based on the disease diagnosis including five groups for five diseases IMH group DR group RD group IMM group and RVO group The control group for the diseases was the IMH group and metabolomic differences were observed These patients are usually treated with PPV during PPV typically performed on these patients vitreous fluid is usually disposed of as waste and investigators collected 100-250 ul of the fluid for NMR analysis to see metabolomic characterization of these diseases
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None